Global Tumor Embolization Market Size, Status and Forecast 2020-2026

Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Tumor Embolization Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Tumor Embolization Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Trans-Arterial Embolization (TAE)
  • 1.4.3 Drug-Eluting Bead Chemoembolization (DEB-TACE)
  • 1.4.4 Radioembolization (RE)
  • 1.4.5 Others
• 1.5 Market by Application
  • 1.5.1 Global Tumor Embolization Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals
  • 1.5.3 Ambulatory Surgical Centers
  • 1.5.4 Specialty Clinics
  • 1.5.5 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends by Regions

• 2.1 Tumor Embolization Market Perspective (2015-2026)
• 2.2 Tumor Embolization Growth Trends by Regions
  • 2.2.1 Tumor Embolization Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Tumor Embolization Historic Market Share by Regions (2015-2020)
  • 2.2.3 Tumor Embolization Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Tumor Embolization Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Tumor Embolization Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Tumor Embolization Players by Market Size
  • 3.1.1 Global Top Tumor Embolization Players by Revenue (2015-2020)
  • 3.1.2 Global Tumor Embolization Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Tumor Embolization Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Tumor Embolization Market Concentration Ratio
  • 3.2.1 Global Tumor Embolization Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Tumor Embolization Revenue in 2019
• 3.3 Tumor Embolization Key Players Head office and Area Served
• 3.4 Key Players Tumor Embolization Product Solution and Service
• 3.5 Date of Enter into Tumor Embolization Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Tumor Embolization Historic Market Size by Type (2015-2020)
• 4.2 Global Tumor Embolization Forecasted Market Size by Type (2021-2026)

5 Tumor Embolization Breakdown Data by Application (2015-2026)

• 5.1 Global Tumor Embolization Market Size by Application (2015-2020)
• 5.2 Global Tumor Embolization Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Tumor Embolization Market Size (2015-2020)
• 6.2 Tumor Embolization Key Players in North America (2019-2020)
• 6.3 North America Tumor Embolization Market Size by Type (2015-2020)
• 6.4 North America Tumor Embolization Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Tumor Embolization Market Size (2015-2020)
• 7.2 Tumor Embolization Key Players in Europe (2019-2020)
• 7.3 Europe Tumor Embolization Market Size by Type (2015-2020)
• 7.4 Europe Tumor Embolization Market Size by Application (2015-2020)

8 China

• 8.1 China Tumor Embolization Market Size (2015-2020)
• 8.2 Tumor Embolization Key Players in China (2019-2020)
• 8.3 China Tumor Embolization Market Size by Type (2015-2020)
• 8.4 China Tumor Embolization Market Size by Application (2015-2020)

(2015-2020)

(2015-2020)

9 Key Players Profiles

• 9.1 Boston Scientific Corporation
  • 9.1.1 Boston Scientific Corporation Company Details
  • 9.1.2 Boston Scientific Corporation Business Overview and Its Total Revenue
  • 9.1.3 Boston Scientific Corporation Tumor Embolization Introduction
  • 9.1.4 Boston Scientific Corporation Revenue in Tumor Embolization Business (2015-2020))
  • 9.1.5 Boston Scientific Corporation Recent Development
• 9.2 Varian Medical Systems, Inc.
  • 9.2.1 Varian Medical Systems, Inc. Company Details
  • 9.2.2 Varian Medical Systems, Inc. Business Overview and Its Total Revenue
  • 9.2.3 Varian Medical Systems, Inc. Tumor Embolization Introduction
  • 9.2.4 Varian Medical Systems, Inc. Revenue in Tumor Embolization Business (2015-2020)
  • 9.2.5 Varian Medical Systems, Inc. Recent Development
• 9.3 Nordion (Sotera Health)
  • 9.3.1 Nordion (Sotera Health) Company Details
  • 9.3.2 Nordion (Sotera Health) Business Overview and Its Total Revenue
  • 9.3.3 Nordion (Sotera Health) Tumor Embolization Introduction
  • 9.3.4 Nordion (Sotera Health) Revenue in Tumor Embolization Business (2015-2020)
  • 9.3.5 Nordion (Sotera Health) Recent Development
• 9.4 Sirtex Medical
  • 9.4.1 Sirtex Medical Company Details
  • 9.4.2 Sirtex Medical Business Overview and Its Total Revenue
  • 9.4.3 Sirtex Medical Tumor Embolization Introduction
  • 9.4.4 Sirtex Medical Revenue in Tumor Embolization Business (2015-2020)
  • 9.4.5 Sirtex Medical Recent Development

10 Analyst's Viewpoints/Conclusions

11 Appendix

• 11.1 Research Methodology
  • 11.1.1 Methodology/Research Approach
  • 11.1.2 Data Source
• 11.2 Disclaimer